ACC Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 17 Aug 2026 | Cement & Cement Products | Market Cap: ₹24.6K Cr

Ambuja Cements expects consolidated volume growth of around 8%-10% in FY '27, targeting approximately 80 million tonnes, supported by stabilization and ramp-up of acquired assets like Sanghi and Penna, and commissioning of ongoing expansions adding about 10 million tonnes capacity. Ambuja Cements targets volume growth to around 8-10% in FY '27, aiming for about 80 million tonnes, aided by stabilizing acquired assets (Sanghi, Penna) and commissioning ongoing expansions adding ~10 million tonnes capacity.

From ACC's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

1,307.4

Market Cap

₹24.6K Cr

P/E Ratio

12.9

How does ACC rank in Cement & Cement Products?

Compare ACC against every Cement & Cement Products company this quarter on revenue, margins and earnings-call signals.

View Cement & Cement Products leaderboard →

ACC — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹7.1K Cr, net profit ₹238 Cr.

Full financials →

📊 Revenue & Sales Performance

  • Ambuja Cements expects consolidated volume growth of around 8%-10% in FY '27, targeting approximately 80 million tonnes, supported by stabilization and ramp-up of acquired assets like Sanghi and Penna, and commissioning of ongoing expansions adding about 10 million tonnes capacity.
  • Industry growth is anticipated to be softer at around 5%-5.5% for FY '27, impacted by inflation and weak monsoon.
  • The company plans to focus on optimizing existing capacities and improving utilization rates (e.g., Sanghi at 65%-70%, Penna at 55%-60%, others around 75%-80%).
  • Growth strategy emphasizes trade volume and premium cement sales, with premium products constituting roughly 36% of trade sales, a figure they aim to sustain or improve gradually.
  • Capacity expected to reach roughly 119 million tonnes by end of FY '27, with recalibrated growth plans focusing on disciplined capital allocation and operational efficiency rather than aggressive expansion.
  • Longer-term capacity target shifted from FY '28 to possibly FY '30 due to measured approach and market conditions.

📈 Profitability & Margins

  • Ambuja Cements targets volume growth to around 8-10% in FY '27, aiming for about 80 million tonnes, aided by stabilizing acquired assets (Sanghi, Penna) and commissioning ongoing expansions adding ~10 million tonnes capacity.
  • Cost per tonne peaked at INR4,500 in Q4 FY '26 with an expected reduction journey: INR250/tonne cost reduction targeted in FY '27 and another INR250/tonne in FY '28, aiming for INR4,000 per tonne by March 2028.
  • EBITDA per tonne guidance is cautious; focus is on cost control and premium product mix, with some price improvement (~INR10 in March quarter) but pricing pressure persists due to softer demand.
  • Capex is moderate (INR6,000-6,500 crores in FY '27) focusing on organic growth, optimizing current assets, and selective new projects (Mundra clinker plant, limestone block in Assam).
  • Management believes internal execution and cost improvements will drive margin expansion despite external uncertainties.
  • No formal EPS or profit guidance yet; updates expected in coming quarters as conditions clarify.

🏗️ Capital Expenditure Plans

  • Current capex under execution is around INR4 billion, including capacity expansion, Waste Heat Recovery Systems (WHRS), and fly ash transportation systems.
  • Annual capex guidance is INR65-70 billion for the next 2 years, focused on debottlenecking and maintenance.
  • Two new clinker capacity projects planned: Mundra (2 million tonnes) and Assam (limestone block acquisition) to begin by end of the year, aiming for commissioning within 24-28 months.
  • The Maratha plant will add 4 million tonnes, increasing clinker capacity from 69 to 73 million tonnes.
  • Emphasis on disciplined capital allocation prioritizing organic growth and stabilizing acquired assets (Sanghi, Penna).
  • No immediate plans to aggressively pursue inorganic growth; focus remains on organic expansions and improving existing assets' utilization.
  • Future capex plans are being recalibrated with a more gradual approach, prioritizing capital efficiency and maximizing returns.

💰 Fundraising & Capital Structure

Based on the information from pages 16-20 of the Ambuja Cements Limited transcript dated May 04, 2026: - There is no explicit mention of any current or planned new fundraising through debt or equity in the provided text. - The company is focusing on disciplined capital allocation with an emphasis on completing ongoing capex projects before initiating new ones. - Capex guidance for the next 2 years is around INR 65-70 billion, primarily funded through internal resources and focused on organic growth. - Karan Adani mentioned a focus on achieving an 18% IRR for equity investments in capex but did not indicate new external fundraising. - The company appears to be cautious and calibrated in capital spending given past delays and is prioritizing cost control and stabilization over aggressive expansion. - Inorganic growth or acquisitions are being evaluated but not indicated as a priority currently. No clear indication of impending debt or equity fundraising was given.

📋 Order Book & Pipeline

The provided transcript from Ambuja Cements Limited's Q4 FY '26 Earnings Call does not explicitly mention details about the current or expected order book or pending orders. The discussion primarily focuses on: - Capacity utilization and expansion plans - Cost and pricing dynamics - Branding and advertisement expenses - Operational reset and key performance indicators - Market demand outlook and volume growth projections - Capex plans and strategic focus on organic growth There is no specific information on the quantum or status of current or pending orders in the provided pages. For precise order book data, a separate section of the earnings report or investor presentation would need to be referenced.

Key Metrics

Others in Cement & Cement Products this season

  • Shree Cement (Q4 FY26)

    11% volume growth was recorded in Q4 FY26, signaling positive short-term momentum (Page 17). Key concall takeaways from Shree Cement's Q4 FY26 earnings call…

  • Orient Cement (Q4 FY26)

    Capex moderated to INR6,000-6,500 crores in FY '27, emphasizing organic growth, stabilization of acquired assets, and selective capacity expansions. Key…

  • India Cements (Q4 FY26)

    Volume growth continues with Q4 FY26 consolidated sales volumes at 44 million tons and UltraTech brand volumes growing 19% YoY. Key concall takeaways from…

  • Star Cement (Q4 FY26)

    Revenue increased from INR3,163 crores in FY25 to INR3,776 crores in FY26. Key concall takeaways from Star Cement Ltd's Q4 FY26 earnings call — and how it…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were ACC Q4 FY26 results?

Ambuja Cements expects consolidated volume growth of around 8%-10% in FY '27, targeting approximately 80 million tonnes, supported by stabilization and ramp-up of acquired assets like Sanghi and Penna, and commissioning of ongoing expansions adding about 10 million tonnes capacity. Ambuja Cements targets volume growth to around 8-10% in FY '27, aiming for about 80 million tonnes, aided by stabilizing acquired assets (Sanghi, Penna) and commissioning ongoing expansions adding ~10 million tonnes capacity.

What is ACC share price analysis?

ACC currently shows a neutral. The stock trades at a P/E of 12.9 with a market cap of ₹24,551 Cr. Investors should review the full earnings analysis for detailed insights.

Is ACC planning capital expenditure?

Current capex under execution is around INR4 billion, including capacity expansion, Waste Heat Recovery Systems (WHRS), and fly ash transportation systems.

Keep ACC on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.